{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:24:45Z","timestamp":1790623485292,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It is known that patients with rheumatoid arthritis (RA) have a higher risk of coronary heart disease and sudden cardiac death. Abnormalities in cardiac geometry appear to be involved in the setting of the cardiovascular risk, but it has never been specifically investigated in RA. We enrolled 44 patients with RA compared to 131 subjects without RA (normal, N): The RA aged between 18 and 70 years (mean 48.3\u2009\u00b1\u20092.1), 25 females, BMI 27.6\u2009\u00b1\u20090.9; N, of equal age (48.6\u2009\u00b1\u20091.2, n.s.), included 80 females (BMI 26.7\u2009\u00b1\u20090.2, ns). Cardiac Ultrasounds showed an increase of the diameter of the left ventricle but not in the septum with reduction of relative wall thickness (RWT) in the RA population compared to N. Relative wall thickness inversely correlates with biochemical parameters of inflammatory response (gamma globulin, p\u2009&lt;\u20090.03; F\u2009=\u20095,660) and anti citrullinated peptides antibody (anti-CCP Ab) (p\u2009&lt;\u20090.02; F\u2009=\u20097,1620) We conclude that unfavorable cardiac remodeling can increase cardiovascular risk in patients with RA.<\/jats:p>","DOI":"10.1038\/s41598-018-24323-0","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T15:30:39Z","timestamp":1523460639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cardiac eccentric remodeling in patients with rheumatoid arthritis"],"prefix":"10.1038","volume":"8","author":[{"given":"Valeria","family":"Pascale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Finelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5147-4837","authenticated-orcid":false,"given":"Rocco","family":"Giannotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Coscioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Moscato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8997-835X","authenticated-orcid":false,"given":"Guido","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ciccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"key":"24323_CR1","first-page":"2425","volume":"28","author":"T Riise","year":"2001","unstructured":"Riise, T., Jacobsen, B. K. & Gran, J. T. High mortality in patients with rheumatoid arthritis and atlantoaxial subluxation. The Journal of rheumatology 28, 2425\u20132429 (2001).","journal-title":"The Journal of rheumatology"},{"key":"24323_CR2","first-page":"350","volume":"46","author":"A Young","year":"2007","unstructured":"Young, A. et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology 46, 350\u2013357 (2007).","journal-title":"Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology"},{"key":"24323_CR3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1017\/S1120962300020230","volume":"5","author":"GG Neri Serneri","year":"1956","unstructured":"Neri Serneri, G. G. & Von, B. [Heredo-pathology of reactive mesenchymal diseases (so-called collagen diseases). II. Researches on hereditary factors of chronic primary rheumatism]. Acta geneticae medicae et gemellologiae 5, 402\u2013425 (1956).","journal-title":"Researches on hereditary factors of chronic primary rheumatism]. Acta geneticae medicae et gemellologiae"},{"key":"24323_CR4","first-page":"2472","volume":"54","author":"G Einaudi","year":"1963","unstructured":"Einaudi, G. [Investigations of the Diffusion and Characteristics of Cardio-Rheumatological Diseases in the Total Population of a Region of the Province of Turin]. Minerva medica 54, 2472\u20132483 (1963).","journal-title":"Minerva medica"},{"key":"24323_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/rheumatology\/kev330","volume":"55","author":"MG van de Sande","year":"2016","unstructured":"van de Sande, M. G. & Baeten, D. L. Immunopathology of synovitis: from histology to molecular pathways. Rheumatology 55, 599\u2013606 (2016).","journal-title":"Rheumatology"},{"key":"24323_CR6","doi-asserted-by":"crossref","unstructured":"Smolen, J. S., Aletaha, D. & McInnes, I. B. Rheumatoid arthritis. Lancet, (2016).","DOI":"10.1016\/S0140-6736(16)30173-8"},{"key":"24323_CR7","unstructured":"L\u00f3pez-Mej\u00edas R, et al risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers."},{"key":"24323_CR8","first-page":"36","volume":"30","author":"F Wolfe","year":"2003","unstructured":"Wolfe, F., Freundlich, B. & Straus, W. L. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. The Journal of rheumatology 30, 36\u201340 (2003).","journal-title":"The Journal of rheumatology"},{"key":"24323_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","volume":"121","author":"P Joseph","year":"2017","unstructured":"Joseph, P. et al. Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors. Circ Res 121, 677\u2013694 (2017).","journal-title":"Circ Res"},{"key":"24323_CR10","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1161\/CIRCULATIONAHA.106.655688","volume":"114","author":"VJ Dzau","year":"2006","unstructured":"Dzau, V. J. et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation 114, 2850\u20132870 (2006).","journal-title":"Circulation"},{"key":"24323_CR11","first-page":"577","volume":"16","author":"TH Marwick","year":"2015","unstructured":"Marwick, T. H. et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)dagger. European heart journal cardiovascular Imaging 16, 577\u2013605 (2015).","journal-title":"European heart journal cardiovascular Imaging"},{"key":"24323_CR12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0735-1097(94)00473-4","volume":"25","author":"HM Krumholz","year":"1995","unstructured":"Krumholz, H. M., Larson, M. & Levy, D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. Journal of the American College of Cardiology 25, 879\u2013884 (1995).","journal-title":"Journal of the American College of Cardiology"},{"key":"24323_CR13","doi-asserted-by":"crossref","unstructured":"Verdecchia, P. et al. Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension. J Am Heart Assoc 6, (2017).","DOI":"10.1161\/JAHA.117.005948"},{"key":"24323_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1053\/j.semarthrit.2003.09.011","volume":"33","author":"C Gonzalez-Juanatey","year":"2004","unstructured":"Gonzalez-Juanatey, C. et al. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Seminars in arthritis and rheumatism 33, 231\u2013238 (2004).","journal-title":"Seminars in arthritis and rheumatism"},{"key":"24323_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1368-5031.2006.00746.x","volume":"60","author":"N Rexhepaj","year":"2006","unstructured":"Rexhepaj, N. et al. Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease. International journal of clinical practice 60, 683\u2013688 (2006).","journal-title":"International journal of clinical practice"},{"key":"24323_CR16","first-page":"2005","volume":"34","author":"C Meune","year":"2007","unstructured":"Meune, C. et al. Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-Doppler echocardiography study. The Journal of rheumatology 34, 2005\u20132009 (2007).","journal-title":"The Journal of rheumatology"},{"key":"24323_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s10067-005-0014-3","volume":"25","author":"S Arslan","year":"2006","unstructured":"Arslan, S., Bozkurt, E., Sari, R. A. & Erol, M. K. Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease. Clinical rheumatology 25, 294\u2013299 (2006).","journal-title":"Clinical rheumatology"},{"key":"24323_CR18","doi-asserted-by":"crossref","unstructured":"Cader, M. Z. et al. Performance of the 2010 ACR\/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort. Annals of the rheumatic diseases 70 949\u2013955, (2011).","DOI":"10.1136\/ard.2010.143560"},{"key":"24323_CR19","doi-asserted-by":"crossref","unstructured":"Lee, K. E. et al. HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis. Rheumatol Int, (2017).","DOI":"10.1136\/annrheumdis-2017-eular.2363"},{"key":"24323_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1161\/01.HYP.0000150108.37527.57","volume":"45","author":"G de Simone","year":"2005","unstructured":"de Simone, G. et al. Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic underestimation. Hypertension 45, 64\u201368 (2005).","journal-title":"Hypertension"},{"key":"24323_CR21","first-page":"36","volume":"2","author":"D Predeteanu","year":"2009","unstructured":"Predeteanu, D. et al. Anti-cyclic citrullinated peptide antibodies\u2013activity markers in rheumatoid arthritis. Journal of medicine and life 2, 36\u201341 (2009).","journal-title":"Journal of medicine and life"},{"key":"24323_CR22","first-page":"73","volume":"113","author":"E Rezus","year":"2009","unstructured":"Rezus, E., Grigoriu, A. & Rezus, C. [Aggressive nature of rheumatic arthritis with citrullinated cyclic peptide antibodies]. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 113, 73\u201378 (2009).","journal-title":"Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi"},{"key":"24323_CR23","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1136\/annrheumdis-2013-203314","volume":"73","author":"NM Fine","year":"2014","unstructured":"Fine, N. M. et al. Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography. Annals of the rheumatic diseases 73, 1833\u20131839 (2014).","journal-title":"Annals of the rheumatic diseases"},{"key":"24323_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/ar1814","volume":"7","author":"JT Giles","year":"2005","unstructured":"Giles, J. T., Fernandes, V., Lima, J. A. & Bathon, J. M. Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis research & therapy 7, 195\u2013207 (2005).","journal-title":"Arthritis research & therapy"},{"key":"24323_CR25","doi-asserted-by":"publisher","first-page":"e009134","DOI":"10.1136\/bmjopen-2015-009134","volume":"6","author":"AL Svensson","year":"2016","unstructured":"Svensson, A. L. et al. Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial. BMJ open 6, e009134 (2016).","journal-title":"BMJ open"},{"key":"24323_CR26","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM199705083361903","volume":"336","author":"RS Vasan","year":"1997","unstructured":"Vasan, R. S., Larson, M. G., Benjamin, E. J., Evans, J. C. & Levy, D. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. The New England journal of medicine 336, 1350\u20131355 (1997).","journal-title":"The New England journal of medicine"},{"key":"24323_CR27","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/j.jacc.2003.11.064","volume":"43","author":"MH Drazner","year":"2004","unstructured":"Drazner, M. H. et al. Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. Journal of the American College of Cardiology 43, 2207\u20132215 (2004).","journal-title":"Journal of the American College of Cardiology"},{"key":"24323_CR28","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/0002-9149(92)90052-Z","volume":"70","author":"MS Lauer","year":"1992","unstructured":"Lauer, M. S., Evans, J. C. & Levy, D. Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). The American journal of cardiology 70, 1180\u20131184 (1992).","journal-title":"The American journal of cardiology"},{"key":"24323_CR29","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","volume":"33","author":"RS Vasan","year":"1999","unstructured":"Vasan, R. S. et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. Journal of the American College of Cardiology 33, 1948\u20131955 (1999).","journal-title":"Journal of the American College of Cardiology"},{"key":"24323_CR30","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1161\/hc1202.105290","volume":"105","author":"MR Zile","year":"2002","unstructured":"Zile, M. R. & Brutsaert, D. L. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 105, 1503\u20131508 (2002).","journal-title":"Circulation"},{"key":"24323_CR31","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","volume":"103","author":"A Deswal","year":"2001","unstructured":"Deswal, A. et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103, 2055\u20132059 (2001).","journal-title":"Circulation"},{"key":"24323_CR32","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1053-2498(00)00173-X","volume":"19","author":"T Kubota","year":"2000","unstructured":"Kubota, T. et al. Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation 19, 819\u2013824 (2000).","journal-title":"The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation"},{"key":"24323_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1056\/NEJM199007263230405","volume":"323","author":"B Levine","year":"1990","unstructured":"Levine, B., Kalman, J., Mayer, L., Fillit, H. M. & Packer, M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. The New England journal of medicine 323, 236\u2013241 (1990).","journal-title":"The New England journal of medicine"},{"key":"24323_CR34","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1161\/01.CIR.102.25.3060","volume":"102","author":"M Rauchhaus","year":"2000","unstructured":"Rauchhaus, M. et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102, 3060\u20133067 (2000).","journal-title":"Circulation"},{"key":"24323_CR35","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","volume":"27","author":"G Torre-Amione","year":"1996","unstructured":"Torre-Amione, G. et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). Journal of the American College of Cardiology 27, 1201\u20131206 (1996).","journal-title":"Journal of the American College of Cardiology"},{"key":"24323_CR36","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. The New England journal of medicine 377, 1119\u20131131 (2017).","journal-title":"The New England journal of medicine"},{"key":"24323_CR37","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1161\/hc3401.093154","volume":"104","author":"N Sivasubramanian","year":"2001","unstructured":"Sivasubramanian, N. et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104, 826\u2013831 (2001).","journal-title":"Circulation"},{"key":"24323_CR38","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.healun.2004.06.021","volume":"23","author":"MF Berry","year":"2004","unstructured":"Berry, M. F. et al. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation 23, 1061\u20131068 (2004).","journal-title":"The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation"},{"key":"24323_CR39","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1161\/01.CIR.101.21.2518","volume":"101","author":"T Kubota","year":"2000","unstructured":"Kubota, T. et al. Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation 101, 2518\u20132525 (2000).","journal-title":"Circulation"},{"key":"24323_CR40","unstructured":"Illario, M., Iaccarino, G., Piazza, O., Menditto, E. & Coscioni, E. Proceedings of the EIP on AHA: A3 Action Group on Frailty. Transl Med UniSa 13, 1\u20133, (2015)."},{"key":"24323_CR41","first-page":"53","volume":"15","author":"G Liotta","year":"2016","unstructured":"Liotta, G. et al. The European Innovation Partnership on Active and Healthy Ageing Synergies: Protocol for a Prospective Observational Study to Measure the Impact of a Community-Based Program on Prevention and Mitigation of Frailty (ICP - PMF) in Community-Dwelling Older Adults. Transl Med UniSa 15, 53\u201366 (2016).","journal-title":"Transl Med UniSa"},{"key":"24323_CR42","first-page":"60","volume":"53","author":"M Illario","year":"2017","unstructured":"Illario, M. et al. The Italian reference sites of the European innovation partnership on active and healthy ageing: Progetto Mattone Internazionale as an enabling factor. Ann Ist Super Sanita 53, 60\u201369 (2017).","journal-title":"Ann Ist Super Sanita"},{"key":"24323_CR43","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"GBD Disease","year":"2017","unstructured":"Disease, G. B. D., Injury, I. & Prevalence, C. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390, 1211\u20131259 (2017).","journal-title":"Lancet"},{"key":"24323_CR44","doi-asserted-by":"crossref","unstructured":"Filkova, M. et al. Polypharmacy and Unplanned Hospitalizations in Patients with Rheumatoid Arthritis. The Journal of rheumatology, (2017).","DOI":"10.3899\/jrheum.160818"},{"key":"24323_CR45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2011.75","volume":"7","author":"DP Symmons","year":"2011","unstructured":"Symmons, D. P. & Gabriel, S. E. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 7, 399\u2013408 (2011).","journal-title":"Nat Rev Rheumatol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24323-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24323-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24323-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:21:27Z","timestamp":1671596487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24323-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["24323"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-24323-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,12]]},"assertion":[{"value":"28 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5867"}}